These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31097978)

  • 1. Fasting Whole-Body Energy Homeostasis and Hepatic Energy Metabolism in Nondiabetic Humans with Fatty Liver.
    Lattuada G; Radaelli MG; De Cobelli F; Esposito A; Manzoni G; Perra S; Del Maschio A; Castoldi G; Perseghin G
    Oxid Med Cell Longev; 2019; 2019():9796175. PubMed ID: 31097978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.
    Perseghin G; Bonfanti R; Magni S; Lattuada G; De Cobelli F; Canu T; Esposito A; Scifo P; Ntali G; Costantino F; Bosio L; Ragogna F; Del Maschio A; Chiumello G; Luzi L
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E697-703. PubMed ID: 16684857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver.
    Perseghin G; Lattuada G; De Cobelli F; Esposito A; Belloni E; Ntali G; Ragogna F; Canu T; Scifo P; Del Maschio A; Luzi L
    Hepatology; 2008 Jan; 47(1):51-8. PubMed ID: 17955548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal hepatic energy homeostasis in type 2 diabetes.
    Szendroedi J; Chmelik M; Schmid AI; Nowotny P; Brehm A; Krssak M; Moser E; Roden M
    Hepatology; 2009 Oct; 50(4):1079-86. PubMed ID: 19637187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated fasting plasma C-peptide occurs in non-diabetic individuals with fatty liver, irrespective of insulin resistance.
    Perseghin G; Caumo A; Lattuada G; De Cobelli F; Ntali G; Esposito A; Belloni E; Canu T; Ragogna F; Scifo P; Del Maschio A; Luzi L
    Diabet Med; 2009 Sep; 26(9):847-54. PubMed ID: 19719704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
    Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
    Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes.
    Perseghin G; Lattuada G; De Cobelli F; Esposito A; Costantino F; Canu T; Scifo P; De Taddeo F; Maffi P; Secchi A; Del Maschio A; Luzi L
    Diabetologia; 2005 Dec; 48(12):2615-21. PubMed ID: 16261312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation.
    Perseghin G; Scifo P; Danna M; Battezzati A; Benedini S; Meneghini E; Del Maschio A; Luzi L
    Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E556-64. PubMed ID: 12169449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative assessment of intrahepatic fat content in children and adolescents with non-alcoholic fatty liver disease].
    Zhang HX; Fu JF; Huang K; Lai C; Liang L; Jiang KW
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):598-603. PubMed ID: 22898281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum resistin and hepatic fat content in nondiabetic individuals.
    Perseghin G; Lattuada G; De Cobelli F; Ntali G; Esposito A; Burska A; Belloni E; Canu T; Ragogna F; Scifo P; Del Maschio A; Luzi L
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5122-5. PubMed ID: 16968796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.
    Traussnigg S; Kienbacher C; Gajdošík M; Valkovič L; Halilbasic E; Stift J; Rechling C; Hofer H; Steindl-Munda P; Ferenci P; Wrba F; Trattnig S; Krššák M; Trauner M
    Liver Int; 2017 Oct; 37(10):1544-1553. PubMed ID: 28544208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver fat and lipid oxidation in humans.
    Kotronen A; Seppälä-Lindroos A; Vehkavaara S; Bergholm R; Frayn KN; Fielding BA; Yki-Järvinen H
    Liver Int; 2009 Oct; 29(9):1439-46. PubMed ID: 19602132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constant hepatic ATP concentrations during prolonged fasting and absence of effects of Cerbomed Nemos
    Gancheva S; Bierwagen A; Markgraf DF; Bönhof GJ; Murphy KG; Hatziagelaki E; Lundbom J; Ziegler D; Roden M
    Mol Metab; 2018 Jan; 7():71-79. PubMed ID: 29122559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants in Genes Controlling Oxidative Metabolism Contribute to Lower Hepatic ATP Independent of Liver Fat Content in Type 1 Diabetes.
    Gancheva S; Bierwagen A; Kaul K; Herder C; Nowotny P; Kahl S; Giani G; Klueppelholz B; Knebel B; Begovatz P; Strassburger K; Al-Hasani H; Lundbom J; Szendroedi J; Roden M;
    Diabetes; 2016 Jul; 65(7):1849-57. PubMed ID: 27207512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise training reduces intrahepatic lipid content in people with and people without nonalcoholic fatty liver.
    Brouwers B; Schrauwen-Hinderling VB; Jelenik T; Gemmink A; Sparks LM; Havekes B; Bruls Y; Dahlmans D; Roden M; Hesselink MKC; Schrauwen P
    Am J Physiol Endocrinol Metab; 2018 Feb; 314(2):E165-E173. PubMed ID: 29118014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of short-term fasting on liver and skeletal muscle lipid, glucose, and energy metabolism in healthy women and men.
    Browning JD; Baxter J; Satapati S; Burgess SC
    J Lipid Res; 2012 Mar; 53(3):577-586. PubMed ID: 22140269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic inflexibility and insulin resistance in obese adolescents with non-alcoholic fatty liver disease.
    Lee S; Rivera-Vega M; Alsayed HM; Boesch C; Libman I
    Pediatr Diabetes; 2015 May; 16(3):211-8. PubMed ID: 24754380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of in vivo fatty acid metabolism in AFABP/aP2(-/-) mice.
    Baar RA; Dingfelder CS; Smith LA; Bernlohr DA; Wu C; Lange AJ; Parks EJ
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E187-93. PubMed ID: 15367400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity - A randomized trial.
    Winn NC; Liu Y; Rector RS; Parks EJ; Ibdah JA; Kanaley JA
    Metabolism; 2018 Jan; 78():128-140. PubMed ID: 28941598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.
    Schmid AI; Szendroedi J; Chmelik M; Krssák M; Moser E; Roden M
    Diabetes Care; 2011 Feb; 34(2):448-53. PubMed ID: 21216854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.